By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Goodwin Biotechnology, Inc. 

1850 NW 69th Avenue

Plantation  Florida  33313  U.S.A.
Phone: 954-321-5300 Fax: 954-587-6378



Company News
Goodwin Biotechnology, Inc. Release: Finding Solutions That Help A Unique Monoclonal Antibody Advance The Fight Against Metastatic Breast Cancer 4/19/2017 8:41:30 AM
Goodwin Biotechnology, Inc. Expands Its ADC Capabilities With A High Containment Suite For Development And cGMP Manufacturing Of Cytotoxic ADCs 5/18/2016 8:17:25 AM
IBC Generium Selects Goodwin Biotechnology, Inc. To Optimize The Process, Scale-Up, And Manufacture An Igg-Based Bispecific Antibody For Phase I Clinical Trials 4/28/2016 6:05:01 AM
Goodwin Biotechnology, Inc. Teams With Panacea Pharmaceuticals, Inc. In Overcoming A Significant Bioconjugation Challenge For An Anti-Cancer Monoclonal Antibody 2/1/2016 7:38:19 AM
Goodwin Biotechnology, Inc. Announces The Completion Of cGMP Manufacturing Of An IgM Monoclonal Antibody And IgM : Ligand Conjugate For Q Therapeutics, Inc., And Successful Clearance Of Q Therapeutics' IND Submission For Q-Cells Cell Therapy In ALS 7/13/2015 7:20:55 AM
Goodwin Biotechnology, Inc. And Aspyrian Therapeutics Collaborate On The Successful GMP Manufacturing And IND Submission For A Novel Antibody Drug Conjugate (ADC) Platform 6/9/2015 7:39:58 AM
Goodwin Biotechnology, Inc. Was Selected By Panacea Pharmaceuticals, Inc. For A Highly Specialized Vaccine Fill / Finish Project 5/11/2015 10:31:55 AM
Goodwin Biotechnology, Inc. And Transporin Announce A Technology Collaboration That Enhances The Ability Of Antibody Drug Conjugates To Target And Deliver Payloads Into Diseased Cells 1/28/2015 7:30:23 AM
Goodwin Biotechnology, Inc. Announces the Appointment of SooYoung S. Lee, PhD as Chief Operating Officer 9/12/2013 9:28:43 AM
Goodwin Biotechnology, Inc. Announces Process Development Sub-Contract for an Anthrax Vaccine 6/3/2013 11:35:10 AM